Current Osteoporosis News and Events | Page 25

Current Osteoporosis News and Events, Osteoporosis News Articles.
Sort By: Most Relevant | Most Viewed
Page 25 of 25 | 1000 Results
Brain estrogen shows promise as schizophrenia treatment
An estrogenic drug that influences neurotransmitter and neuronal systems in the brain is showing promise as an effective therapy for women who suffer from schizophrenia. (2010-03-30)

Promoting healing by keeping skeletal stem cells 'young'
Scientists seeking new ways to fight maladies ranging from arthritis and osteoporosis to broken bones that won't heal have cleared a formidable hurdle, pinpointing and controlling a key molecular player to keep stem cells in a sort of extended infancy. It's a step that makes treatment with the cells in the future more likely for patients. (2010-03-30)

Singapore program to provide clinical insight; showcase for regional research
An exciting scientific program is planned for the IOF Regionals: Asia-Pacific Osteoporosis Meeting, to be held in Singapore from Dec. 10-13, 2010. It will provide clinicians, orthopaedists and other health professionals with the latest information on prevention, diagnosis and treatment of osteoporosis and related fractures. Delegates are invited to showcase their research by submitting abstracts for publication in Osteoporosis International. This is a unique opportunity to provide international visibility for regional research in one of the field's most cited bone journals. (2010-03-24)

Benefits of osteoporosis treatments outweigh possible risk of rare femoral fractures
The occurrence of an unusual type of fracture of the femur, or the thigh bone, is very low in patients with osteoporosis, including those treated with the drug family known as bisphosphonates, according to a new study led by a team of UCSF epidemiologists. (2010-03-24)

Vitamin D levels have different effects on atherosclerosis in blacks and whites
Vitamin D is quickly becoming the (2010-03-15)

Vertebroplasty for patients with osteoporosis provides effective pain relief
Patient selection is key for vertebroplasty -- a minimally invasive treatment performed by interventional radiologists in individuals with painful osteoporotic vertebral compression fractures that fail to respond to conventional medical therapy -- to be effective and successful, according to a study of more than 1,500 persons who were followed over seven years. Additionally, collaboration between an interventional radiologist and other medical experts in treating a patient is imperative, say researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla. (2010-03-15)

Satellite symposia enhance scientific program with quality information and practical new knowledge
The IOF WCO-ECCEO10, to be held from May 5-8, 2010, in Florence, Italy, will feature a challenging scientific program that includes twelve nonconcurrent satellite symposia organized by leading companies in the bone field and led by internationally renowned bone experts. Covering a broad spectrum of clinically oriented topics, the symposia offer a wealth of quality information and practical new knowledge for the improved care of osteoporosis patients worldwide. (2010-03-15)

Osteoporosis drug improves healing after rotator cuff surgery
Tears in the shoulder's rotator cuff, a common sports injury, are painful and restricting. New research shows an approved therapy for osteoporosis, Forteo, may speed healing and improve patient outcomes, according to a preliminary study from Hospital for Special Surgery in New York. (2010-03-10)

Quantity vs. quality: Long-term use of bone-building osteoporosis drugs
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons. (2010-03-10)

Adele Boskey 2010 recipient of ORS/AOA award for lifetime contributions to orthopedics
Biomineralization and osteoporosis investigator Adele L. Boskey, Ph.D., the Starr Chair in Mineralized Tissue Research at Hospital for Special Surgery in New York, has been selected the 2010 recipient of the Orthopedic Research Society/American Orthopaedic Association Alfred R. Shands, Jr. Award. The award will be presented to Dr. Boskey on Monday, March 8, at the 56th Annual Meeting of the Orthopedic Research Society in New Orleans. (2010-03-08)

McGill, Quebec biotech firm partner for new bone-disease treatment
Dr. Marc McKee of McGill University is collaborating closely with Enobia Pharma Inc., a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth. (2010-03-05)

Pharmacists can play key role in fight against osteoporosis: U of A study
University of Alberta researcher Nese Yuksel shows how pharmacists can help in the fight against osteoporosis, a disease that often goes undiagnosed. (2010-03-03)

Common osteoporosis drugs are associated with a decrease in risk of breast cancer
Women who take some types of bone-building drugs used to prevent and treat osteoporosis may be at lower risk of breast cancer, according to a study by US researchers led by Fred Hutchinson Cancer Research Center. (2010-03-02)

Record number of abstracts received for the World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
More than 850 abstracts have been received -- guaranteeing broad global attendance at the year's most noteworthy platform for osteoporosis research. Don't miss the most important osteoporosis meeting of 2010, to be held in the center of Florence, Italy, from May 5-8, 2010. (2010-02-18)

Attend the most exciting bone meeting in the Asia-Pacific region in 2010
The International Osteoporosis Foundation invites you to attend the IOF Regionals: 1st Asia-Pacific Osteoporosis Meeting to be held in Singapore from December 10-13, 2010. (2010-02-14)

Diabetes drug ups risk for bone fractures in older women
A Henry Ford Hospital study finds women with type 2 diabetes who take a commonly prescribed class of medications to treat insulin resistance may be at a higher risk for developing bone fractures. After taking a thiazolidinedione (TZD) for one year, women are 50 percent more likely to have a bone fracture than patients not taking TZDs, according to study results. And those at the greatest risk for fractures from TZD use are women older than 65. (2010-02-10)

Multicenter study finds little effect of soy isoflavones on bone loss in postmenopausal women
Results from a new multicenter clinical trial of 224 postmenopausal women questions the value of consuming soy isoflavone tablets to help lessen bone loss and minimize the effect of osteoporosis. (2010-02-09)

Inhibiting serotonin in gut could cure osteoporosis
An investigational drug that inhibits serotonin in the gut, administered orally once daily, effectively cured osteoporosis in mice and rats, reports a new paper in Nature Medicine. Serotonin in the gut has been shown in recent research to stall bone formation. The finding could lead to new therapies that build new bone; most osteoporosis drugs only prevent the breakdown of old bone. (2010-02-07)

Grandpa's broken hip may mean weaker bones for his grandsons
If your grandfather has had a hip fracture, you too could be at risk. Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have been able to show, for the first time, a link between hip fractures in elderly men and impaired bone health in their grandsons. (2010-01-29)

World Congress on Osteoporosis 2010 -- IOF WCO -- ECCEO10
The abstract submission deadline of Feb. 4 is only one week away. Ensure that your research appears at the most important international osteoporosis meeting of the year, the IOF WCO-ECCEO10. Abstracts will be published in the field's leading journal, Osteoporosis International. (2010-01-28)

Female athletes injured more than male athletes
Female athletes experience dramatically higher rates of specific musculoskeletal injuries and medical conditions compared to male athletes. That's because many training programs developed for female athletes are built on research using young adult males and don't take the intrinsic biological differences between the sexes into account. (2010-01-25)

World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
Don't miss the most important osteoporosis-related event of 2010, to be held in the center of Florence, Italy, from May 5-8, 2010. Early bird rates still available! (2010-01-19)

University of Pittsburgh researchers launching trial of new osteoporosis drug
Endocrinologists at the University of Pittsburgh School of Medicine and UPMC are launching a human trial of a new drug that their research indicates holds great promise for building bones weakened by osteoporosis. An experimental drug called parathyroid hormone-related protein is an anabolic agent that appears to be unique in its ability to stimulate bone formation without simultaneously increasing bone breakdown. (2010-01-14)

World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
Register now for the most important osteoporosis conference of 2010: the IOF WCO-ECCEO10. Take advantage of lower rates, register before the early bird registration deadline of Jan. 15. Submit your abstract by Feb. 4. (2010-01-14)

UC Davis research confirms benefits of calcium and vitamin D in preventing fractures
Taking both calcium and vitamin D supplements on a daily basis reduces the risk of bone fractures, regardless of whether a person is young or old, male or female, or has had fractures in the past, a large study of nearly 70,000 patients from throughout the United States and Europe has found. (2010-01-14)

HIV-infected postmenopausal women at high risk for bone fractures
According to a new study accepted for publication in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism, postmenopausal HIV-infected women have a high prevalence of low bone mineral density and high bone turnover placing them at high risk for future bone fractures. (2010-01-05)

World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
Register now for the largest global scientific meeting devoted exclusively to osteoporosis and osteoarthritis in 2010. Only 10 days until the early registration deadline! (2010-01-05)

How to build bone: Separate bone formation from bone destruction
Treatments for osteoporosis need to increase the amount and/or quality of bone. As bone formation is tightly coupled to bone destruction, researchers looking to develop new approaches to build bone in individuals with osteoporosis need to identify ways to separate the two processes. New research has now identified one way to do this in mice. (2010-01-04)

Nanoscale changes in collagen are a tipoff to bone health
Using a technique that provides detailed images of nanoscale structures, researchers at the University of Michigan and Detroit's Henry Ford Hospital have discovered changes in the collagen component of bone that directly relate to bone health. (2009-12-22)

We now know that the brain controls the formation of bone
The brain acts as a profound regulatory center, controlling myriad processes throughout the body in ways we are only just beginning to understand. In new findings, Australian scientists have shown surprising connections between the brain and regulation of bone mass. (2009-12-21)

Skull bone may hold the key to tackling osteoporosis
Scientists at Queen Mary, University of London have uncovered fundamental differences between the bone which makes up the skull and the bones in our limbs, which they believe could hold the key to tackling bone weakness and fractures. (2009-12-18)

Announcing IOF Regionals 1st Asia-Pacific osteoporosis meeting
Mark December 10-13, 2010, on your calendar and don't miss this important scientific event, organized by the International Osteoporosis Foundation. (2009-12-17)

NICE guidelines ration affordable osteoporosis drugs
Low cost osteoporosis drugs are strictly rationed for the under-75s, and UK physicians hampered by restrictive guidelines, according to findings which appear today in the journal Therapeutic Advances in Musculoskeletal Disease, published by SAGE. A leading Cambridge University bone health expert has outlined flaws in NICE osteoporosis treatment guidance, which limits options for many postmenopausal women in the under-75 age bracket. (2009-12-11)

Register now online for the World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
Take advantage of lower early bird registration rates and register online now for the premiere osteoporosis congress of 2010. Submit your abstract online before Feb. 4, 2010, and ensure that your research appears in the program and abstract book published as a supplement issue of the field's leading journal, Osteoporosis International. (2009-11-30)

A RANK insider resolving the enigma of the fever chart
Mammals have evolved a complex system for controlling bone remodeling. Babies require calcium for healthy bones and they obtain it from their mother's milk. Nursing mothers release calcium from their bones. Surprisingly, however, the same system also plays a key part in the control of fever and of female body temperature. This finding is reported in a paper in this week's issue of Nature from Josef Penninger's group at the IMBA in Vienna. (2009-11-25)

Flaxseed oil and osteoporosis
Animal studies suggest that adding flaxseed oil to the diet could reduce the risk of osteoporosis in post-menopausal women and women with diabetes, according to a report to be published in the International Journal of Food Safety, Nutrition and Public Health. (2009-11-23)

Special sessions announced for World Congress on Osteoporosis 2010-IOF WCO-ECCEO10
Researchers are invited to contribute their abstracts to the World Congress on Osteoporosis 2010, the largest global meeting devoted to all aspects of osteoporosis and osteoarthritis research and patient care. The Congress will be held in Florence, Italy, from May 5-8, 2010. Beginning today, abstracts can be submitted online. The submission deadline is Feb. 4, 2010. (2009-11-20)

New cause of osteoporosis: Mutation in a miroRNA
Many biological processes are controlled by small molecules known as microRNAs. Researchers have now identified a previously unknown microRNA (miR-2861) as crucial to bone maintenance in mice and humans; significantly, expression of functional miR-2861 was absent in two related adolescents with primary osteoporosis. (2009-11-16)

JCI online early table of contents: Nov. 16, 2009
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Nov. 16 2009, in the JCI, including: New cause of osteoporosis: mutation in a miroRNA; Watching Lyme disease-causing microbes move in ticks; MIFfed about protection for the heart; Th22 immune cell subset: a therapeutic target in chronic inflammatory skin disorders?; Loop the loop: speeding up a serious blood vessel condition; and others. (2009-11-16)

Heart and bone damage from low vitamin D tied to declines in sex hormones
Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone. (2009-11-15)

Page 25 of 25 | 1000 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to